Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-006733

Chief Technology Officer sold 14,322 shares at $7.23 ($103,476)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2025-01-15 Sale −14,322 $7.23 $103,476 96,790 D
Open-market sales · 14,322 sh · avg $7.23 · $103,476
Loading xslF345X05/ownership.xml…